Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00390260 | Effect of Rofecoxib and a Narcotic Analgesic to Treat Pain Following Arthroscopic Surgery (0966-179)(COMPLETED) | PHASE3 | COMPLETED | 420 | — | — | Feb 1, 2002 | Feb 1, 2003 | Feb 2, 2017 | - | — |
| Name | Type | Description |
|---|---|---|
| MK0966 / Duration of Treatment: 1 Days | DRUG | - |
| Comparator: acetaminophen (+) hydrocodone bitartrate / Duration of Treatment: 1 Days | DRUG | - |
| Comparator: placebo (unspecified) / Duration of Treatment: 1 Days | DRUG | - |
Inclusion Criteria: * Elective outpatient arthroscopic knee surgery expected to last \<= 90 minutes using general anesthesia * Patients must experience moderate to severe pain following surgery * Patient must be in general good health as judged by the primary investigator Exclusion Criteria: * Os...